According to the New York Times Democrats in Congress asked for two separate investigations of drug industry pricing Wednesday following news reports of unusually high wholesale price increases in brand-name prescription drugs. Four House leaders and one senator asked for government reviews of the pricing practices of the drug companies. The price increases could add more than $10 billion to the nation’s drug bill, which is on track to exceed $300 billion this year.